Guideline and preliminary clinical practice results for dose specification and target delineation for postoperative radiotherapy for oral cavity cancer

Shih Hua Liu, K. S Clifford Chao, Yi Shing Leu, Jehn Chuan Lee, Chung Ji Liu, Yu Chuen Huang, Yi Fang Chang, Hong Wen Chen, Jo Ting Tsai, Yu Jen Chen

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background Surgery followed by radiotherapy (RT) is indicated for patients with high-risk oral cavity cancer (OCC). Based on multi-institutional reports, we developed a guideline for postoperative RT for patients with OCC. Methods A multidisciplinary OCC team was recruited to develop a questionnaire concerning details of risk-factor categorization, target delineation, and dose specification. Thirty-one radiation oncologists from 18 institutions completed the questionnaire, and data were subjected to extensive review to establish the guideline by expert meeting. In this study, we also report the results for patients treated in accordance with the guideline at our institution between 2007 and 2011. Results Forty-one patients received RT compatible with this guideline with a median 26.8-month follow-up. Thirty-two patients (78%) remained disease-free, 6 (15%) developed locoregional recurrence (4 in-field, 1 marginal, and 1 out-field) and 4 (10%) developed distant metastasis. The overall 2-year survival rate was 86.7%. Conclusion This guideline is promising and should be validated and refined in further clinical practice.

Original languageEnglish
Pages (from-to)933-939
Number of pages7
JournalHead and Neck
Volume37
Issue number7
DOIs
Publication statusPublished - Jul 1 2015

Fingerprint

Mouth Neoplasms
Mouth
Radiotherapy
Guidelines
Survival Rate
Neoplasm Metastasis
Recurrence
Surveys and Questionnaires

Keywords

  • dose specification
  • guideline
  • oral cavity cancer
  • postoperative radiotherapy
  • target delineation

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Guideline and preliminary clinical practice results for dose specification and target delineation for postoperative radiotherapy for oral cavity cancer. / Liu, Shih Hua; Chao, K. S Clifford; Leu, Yi Shing; Lee, Jehn Chuan; Liu, Chung Ji; Huang, Yu Chuen; Chang, Yi Fang; Chen, Hong Wen; Tsai, Jo Ting; Chen, Yu Jen.

In: Head and Neck, Vol. 37, No. 7, 01.07.2015, p. 933-939.

Research output: Contribution to journalArticle

Liu, Shih Hua ; Chao, K. S Clifford ; Leu, Yi Shing ; Lee, Jehn Chuan ; Liu, Chung Ji ; Huang, Yu Chuen ; Chang, Yi Fang ; Chen, Hong Wen ; Tsai, Jo Ting ; Chen, Yu Jen. / Guideline and preliminary clinical practice results for dose specification and target delineation for postoperative radiotherapy for oral cavity cancer. In: Head and Neck. 2015 ; Vol. 37, No. 7. pp. 933-939.
@article{d74701ffa3d84febb9bc1c89ece1bae5,
title = "Guideline and preliminary clinical practice results for dose specification and target delineation for postoperative radiotherapy for oral cavity cancer",
abstract = "Background Surgery followed by radiotherapy (RT) is indicated for patients with high-risk oral cavity cancer (OCC). Based on multi-institutional reports, we developed a guideline for postoperative RT for patients with OCC. Methods A multidisciplinary OCC team was recruited to develop a questionnaire concerning details of risk-factor categorization, target delineation, and dose specification. Thirty-one radiation oncologists from 18 institutions completed the questionnaire, and data were subjected to extensive review to establish the guideline by expert meeting. In this study, we also report the results for patients treated in accordance with the guideline at our institution between 2007 and 2011. Results Forty-one patients received RT compatible with this guideline with a median 26.8-month follow-up. Thirty-two patients (78{\%}) remained disease-free, 6 (15{\%}) developed locoregional recurrence (4 in-field, 1 marginal, and 1 out-field) and 4 (10{\%}) developed distant metastasis. The overall 2-year survival rate was 86.7{\%}. Conclusion This guideline is promising and should be validated and refined in further clinical practice.",
keywords = "dose specification, guideline, oral cavity cancer, postoperative radiotherapy, target delineation",
author = "Liu, {Shih Hua} and Chao, {K. S Clifford} and Leu, {Yi Shing} and Lee, {Jehn Chuan} and Liu, {Chung Ji} and Huang, {Yu Chuen} and Chang, {Yi Fang} and Chen, {Hong Wen} and Tsai, {Jo Ting} and Chen, {Yu Jen}",
year = "2015",
month = "7",
day = "1",
doi = "10.1002/hed.23692",
language = "English",
volume = "37",
pages = "933--939",
journal = "Head and Neck",
issn = "1043-3074",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Guideline and preliminary clinical practice results for dose specification and target delineation for postoperative radiotherapy for oral cavity cancer

AU - Liu, Shih Hua

AU - Chao, K. S Clifford

AU - Leu, Yi Shing

AU - Lee, Jehn Chuan

AU - Liu, Chung Ji

AU - Huang, Yu Chuen

AU - Chang, Yi Fang

AU - Chen, Hong Wen

AU - Tsai, Jo Ting

AU - Chen, Yu Jen

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Background Surgery followed by radiotherapy (RT) is indicated for patients with high-risk oral cavity cancer (OCC). Based on multi-institutional reports, we developed a guideline for postoperative RT for patients with OCC. Methods A multidisciplinary OCC team was recruited to develop a questionnaire concerning details of risk-factor categorization, target delineation, and dose specification. Thirty-one radiation oncologists from 18 institutions completed the questionnaire, and data were subjected to extensive review to establish the guideline by expert meeting. In this study, we also report the results for patients treated in accordance with the guideline at our institution between 2007 and 2011. Results Forty-one patients received RT compatible with this guideline with a median 26.8-month follow-up. Thirty-two patients (78%) remained disease-free, 6 (15%) developed locoregional recurrence (4 in-field, 1 marginal, and 1 out-field) and 4 (10%) developed distant metastasis. The overall 2-year survival rate was 86.7%. Conclusion This guideline is promising and should be validated and refined in further clinical practice.

AB - Background Surgery followed by radiotherapy (RT) is indicated for patients with high-risk oral cavity cancer (OCC). Based on multi-institutional reports, we developed a guideline for postoperative RT for patients with OCC. Methods A multidisciplinary OCC team was recruited to develop a questionnaire concerning details of risk-factor categorization, target delineation, and dose specification. Thirty-one radiation oncologists from 18 institutions completed the questionnaire, and data were subjected to extensive review to establish the guideline by expert meeting. In this study, we also report the results for patients treated in accordance with the guideline at our institution between 2007 and 2011. Results Forty-one patients received RT compatible with this guideline with a median 26.8-month follow-up. Thirty-two patients (78%) remained disease-free, 6 (15%) developed locoregional recurrence (4 in-field, 1 marginal, and 1 out-field) and 4 (10%) developed distant metastasis. The overall 2-year survival rate was 86.7%. Conclusion This guideline is promising and should be validated and refined in further clinical practice.

KW - dose specification

KW - guideline

KW - oral cavity cancer

KW - postoperative radiotherapy

KW - target delineation

UR - http://www.scopus.com/inward/record.url?scp=84931564016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931564016&partnerID=8YFLogxK

U2 - 10.1002/hed.23692

DO - 10.1002/hed.23692

M3 - Article

C2 - 24634078

AN - SCOPUS:84931564016

VL - 37

SP - 933

EP - 939

JO - Head and Neck

JF - Head and Neck

SN - 1043-3074

IS - 7

ER -